Madrid, February 19-22th 2020: Defymed is happy to announce that we won the “Startup Grant for the Technology Fair”  and are invited to participate to the 13th International ATTD (Advanced Technol​ogies & Treatments for Diabetes) conference, taking place in Madrid, Spain. We will share the booth with our partner Kadimastem.

We will be located in a booth and will be very happy to meet you there! Our booth will be on the International Fair of New Technologies in Diabetes where start-ups and emerging companies will be displaying cutting edge technologies and medical devices for diabetes treatment. Moreover, Defymed’s Business developer, Dr Manuel PIRES, will be presenting the latest developments of ENCAPSULIN (MailPan® by Defymed and insulin-secreting-cells by Kadimastem) at :

  1. the session entitled:  PRESENTATION OF START-UP COMPANIES on saturday, 22 February 2020 from 09:30  to 09:35 in the parrallel session #17 in room ROME.
  2. the « ATTD 2020 Technology Fair » in the Exhibition Area on friday, 21 February 2020 from 14:30  to 14:40 in the Exhibition Area.

The conference on ATTD 2020 will present an outstanding scientific program delivered by renowned international experts. ATTD 2020 will showcase the latest developments in new insulin analogues and delivery systems, insulin pumps, glucose sensors, closed-loop systems, devices for diabetic prevention, artificial pancreas, new technologies for treating obesity and many more.

For more info

If you want to meet us, do not hesitate to contact us at : info@defymed.com